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INTRODUCTION
Valvular heart disease (VHD) affects 1 in 50 of 
the general population and 1 in 3 of the over 65s, 
and is associated with increased morbidity and 
premature mortality.1 Among adults presenting 
to hospital with severe VHD, mitral regurgitation 
(MR: 21.3%) is the second and aortic regurgitation 
(AR: 5.3%) is the third most common valve lesion 
after aortic stenosis (41.2%).2 The predominance 
of MR above AR is also found in community- based 
studies, although it is much more common to find 
mild and moderate VHDs than severe disease in 
the general population.1 VHD of all types is more 
common with advancing age, and given the steady 
rise of life expectancy in the Western world, the 
frequency of patients presenting with MR and AR 
is increasing. Despite clear evidence of benefit from 
surgery when performed in a timely fashion, many 
patients undergo operation late in the course of 
disease, with more advanced symptoms and higher 
rates of heart failure and ventricular dysfunction.2 
There is a long latent period in the majority of 
patients with either MR or AR, and timely diag-
nosis, careful monitoring and early referral remain 
critical to care.
HAEMODYNAMICS AND IMAGING OF VALVULAR 
REGURGITATION
The severity of regurgitation through the MV and 
AV is governed by the Gorlin formula, which states 
that flow through an orifice varies by the square root 
of the pressure gradient across the orifice, the dura-
tion of flow and a discharge coefficient.3 Therefore, 
the main determinants of the regurgitant volume 
(RVol) are (1) the size of the regurgitant orifice; 
(2) the pressure gradient between the left ventricle 
(LV) and the left atrium (LA) in MR, and between 
the aortic root and the LV in AR. In most patients, 
the size of the regurgitant orifice is not fixed but 
varies with dynamic changes in geometry, pressure 
and volume. For example, changes in volume status 
can have a significant impact on the assessment of 
MR, with reduction in severity following dialysis 
and after diuretic therapy compared with imaging 
assessment before treatment. Both the dynamic 
nature of the regurgitant orifice and the relation-
ship between pressure and flow mean that images of 
the patient with regurgitation must be understood 
in the context of the haemodynamic status of the 
patient. Therefore, all reports of severity should 
include heart rate and blood pressure, while the 
use of sedation is an important consideration when 
comparing findings on transthoracic echocardiog-
raphy (TTE) and transoesophageal echocardiog-
raphy (TOE). Equally, it should be borne in mind 
that most assessments of MR and AR occur at rest, 
and there may be significant changes on exertion 
(either an increase or decrease in MR, depending 
on the mechanism; and a decrease in AR due to 
the shortening of diastole with higher heart rates). 
Another important factor in assessing regurgita-
tion is the time course of onset: for example, in 
chronic MR, there is chamber dilatation, increased 
LV compliance and lower pulmonary venous pres-
sure, whereas in acute MR, which is usually into a 
low- compliance LV, there is little cavity dilatation 
and high pulmonary venous pressure. In acute MR, 
this means the RVol may be much smaller than 
expected, and even a moderate degree may cause 
symptoms as the LV has not had time to accommo-
date for the MR.4
IDENTIFYING THE MECHANISM OF 
PATHOLOGICAL REGURGITATION
Access to echocardiography is critical for diag-
nosis of valve disease.5 TTE with colour Doppler 
remains the main modality for detection of regur-
gitation. Note that small degrees of physiological 
MR through a structurally normal valve will be 
detected in 10%–20% of children and closing 
volumes in a higher percentage.6 In contrast, 
physiological AR is rare, occurs in less than 1% of 
cases and should be considered pathological until 
proven otherwise.
Once regurgitation has been detected, the key 
step is to determine the cause. This is particularly 
the case in the patient with MR, as the natural 
history, classification of severity and treatment 
choices all depend on whether regurgitation 
is ‘primary’, due to a fault in the valve appa-
ratus, or ‘secondary’, due to disease of the LV 
(table 1). Most cases of AR, on the other hand, 
are secondary to an aortic syndrome, either as 
a result of atherosclerotic aortic root dilatation 
or as part of the aortopathy that can coexist in 
Learning objectives
 ► To understand the advantages and 
disadvantages of imaging techniques in 
identifying aetiology and mechanisms of mitral 
and aortic regurgitation.
 ► To understand the key echocardiographic 
methods of quantifying severity of mitral 
regurgitation (MR) and aortic regurgitation 
(AR), and their advantages and limitations.
 ► To be aware of the relative advantages and 
disadvantages of cardiac magnetic resonance in 
quantifying severity of MR and AR.
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those with a bicuspid aortic valve7 (table 2). In 
both MR and AR, it is good practice to use the 
Carpentier classification to describe abnormalities 
of leaflet motion and thereby define mechanism 
(figures 1–5). This helps to identify the pathology, 
may guide the approach to surgery and can help 
to predict recurrence.8
Identifying structural abnormalities leading 
to MR requires imaging of the leaflets, chordae, 
papillary muscles and annulus at high temporal 
and spatial resolution. 2D TTE is the main method 
to define leaflet thickening (use fundamental 
imaging), leaflet mobility (normal, increased 
(including prolapse) or restricted), degree of 
leaflet coaptation, as well as extent and loca-
tion of calcification (none, mild, moderate and 
severe). 3D TTE is of incremental value in identi-
fying the lesion, leaflet involved and the specific 
valve segments affected, with an accuracy similar 
to multiplane 2D TOE.9 3D TOE has greatest 
accuracy overall compared with surgical findings, 
especially in identifying flail segments and the 
location and extent of prolapsed segments. While 
2D TTE can diagnose the apical displacement of 
the mitral coaptation point, restriction in mobility 
and asymmetric tethering that are typical findings 
in ischaemic MR, 3D TTE and TOE quantify the 
extent of tethering that can direct surgical strat-
egies with greater accuracy.10 Cardiovascular 
magnetic resonance (CMR) can also identify 
leaflet (including segmental) anatomy and motion 
using 2D cine imaging, although true 3D imaging 
is not available. It is best used when echocardiog-
raphy is unable to image the valve adequately.
Visualisation of primary and secondary chordae 
requires good quality 2D TTE imaging in a modi-
fied apical two- chamber view to define location, 
length and thickening, with the transgastric long- 
axis view on 2D TOE also useful to perform these 
measurements and define interpapillary muscle 
distance. 3D TOE can improve on these measures 
but is mainly used to measure annulus size and 
detect annular remodelling that can be specific to 
a disease process, for example, to myxomatous 
or ischaemic MR.11 CMR can accurately locate, 
measure size and track papillary muscle displace-
ment, but the slice thickness (5–7 mm) means that 
it is less useful for imaging the chordae. CMR can 
also identify associated fibrosis or infarction (in 
either the myocardium or papillary muscles),12 
which can inform the assessment of the mech-
anism of MR and likelihood of improvement. 
Contrast- enhanced multislice CT can measure 
mitral annular size with similar accuracy and 
reproducibility to 3D TOE and has the advan-
tage of accurate localisation and quantification of 
calcification.13 As a result, CT has a growing role 
in preprocedural imaging for percutaneous mitral 
intervention but does not yet play the central role 
it performs in assessment for transcatheter aortic 
intervention. It can also assess leaflet motion with 
full cardiac cycle imaging, although the temporal 
resolution is much lower than echocardiography 
or CMR, and the radiation dose is significantly 
higher, so this is generally reserved for rare situa-
tions when neither echocardiography nor CMR is 
able to provide functional information.
In the anatomical assessment of AR, 2D (and to 
some extent 3D) TTE remain the first step in the 
assessment of leaflet mobility, thickening and calci-
fication required to determine mechanism and aeti-
ology. When TTE provides inadequate visualisation 
of structures, or when high spatial and temporal 
resolution imaging is required to assess suitability 
for intervention, for example, with highly eccen-
tric jets and when repair is considered, 2D and 3D 
TOEs provide incremental accuracy.14 Since many 
patients presenting with severe AR have aortic root 
or supracoronary ascending aortic enlargement,7 
an additional requirement is for accurate multi-
planar imaging of the aortic root and ascending 
aorta. Although TTE, TOE and CMR can offer 





  Parachute II
Myxomatous Fibroelastic deficiency II
  Barlow disease II
Degenerative Age- related   
  Mucopolysaccharidoses   
Inflammatory Rheumatic IIIA
  Radiation (lymphoma, breast) IIIA
  Drugs (dopamine agonists) IIIA
  Infective endocarditis IB
  Collagen vascular diseases   
Secondary (ventricular/atrial)   
Ischaemic Myocardial infarction IIIB
  LV dilatation/dysfunction I
Non- ischaemic LV dilatation/dysfunction I
  Left atrium dilatation I
LV, left ventricle.
Table 2 Causes of aortic regurgitation
Primary (valve apparatus)
Congenital Bicuspid, quadricuspid   
  Ventricular septal defect   
Myxomatous Fibroelastic deficiency   
Degenerative Age- related IIIB
  Mucopolysaccharidoses IIIA
Inflammatory Rheumatic IIIA
  Radiation (lymphoma, breast) IIIA
  Drugs (dopamine agonists) IIIA
  Infective endocarditis IB
  Collagen vascular diseases   
Secondary (aortic)     
Congenital Annuloaortic ectasia I
  Loezs- Dietz, Marfan, Ehlers- Danloss I
Acquired Hypertension I
  Atherosclerotic I
  Infection (syphilis) I
  Inflammation (Takayasu) I
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this, multidetector CT provides fast, high resolu-
tion imaging of the aortic root and thoracic aorta 
without limitation by acoustic window and is the 
technique of choice, not least due to the capacity to 
locate and quantify calcification.15
SEVERITY OF REGURGITATION
When quantifying severity of a regurgitant lesion, it 
is important to consider the appearance of (1) the 
valve morphology and (2) the size, shape and func-
tion of the ventricle. For example, if the mitral valve 
leaflets are flail, it is highly likely there is severe 
regurgitation but if you do not think it is severe, 
make sure you have done all you can to be certain. 
Likewise, if the LV is dilated with spherical remod-
elling, if you are going to call any AR moderate, 
make sure you have done all you can to be certain.
Good quality TTE with Doppler can provide 
all the core information required for evaluation of 
regurgitation severity but requires an experienced, 
motivated echocardiographer able to perform the 
necessary integrated assessment of multiple quali-
tative and quantitative parameters, in the knowl-
edge that single measures are subject to variability16 
(table 3). A practical problem is that there is over- 
reliance on colour Doppler, particularly if limited 
to visualisation of the regurgitant jet area, which 
is inaccurate (even if indexed to chamber area).17 
Despite guidelines recommending that regurgi-
tation is quantified using methods including vena 
contracta and flow convergence on colour Doppler, 
many decisions regarding severity of MR are still 
made on echo by visually estimating severity based 
on the size of the colour jet, with some including 
semiquantitative measures (vena contracta width, 
regurgitant orifice area), but only a minority of 
reports provide RVols and fraction.18 Flow conver-
gence, better known as the proximal isovelocity 
surface area (PISA) method, is probably the most 
widely used method used to quantify MR, which 
relies on measuring the radius of a hemisphere 
from the point of aliasing on colour Doppler to 
the vena contracta of the jet. The effective regur-
gitant orifice (EROA) is then calculated from the 
maximal velocity of the regurgitant jet, and the 
RVol by multiplying this with the velocity time inte-
gral of the MR jet.19 Although quantitative grading 
of MR is an important independent imaging marker 
of outcome,20 it involves a number of assumptions 
and calculation from multiple measurements, with 
significant variation between expert readers, and 
there is increasing awareness of inaccuracy where 
the MR does not form a true hemisphere, particu-
larly in functional regurgitation.21
The assessment of AR severity with echocardi-
ography is more challenging than that of MR. On 
TTE, the AR jet is seen with the highest resolution 
in the parasternal long- axis view, which can be 
used to measure vena contracta and jet width rela-
tive to the left ventricular outflow tract. In this 
Figure 1 Carpentier type 1A, normal leaflet motion: annular dilatation (A) mitral regurgitation and (B) aortic regurgitation.
Figure 2 Carpentier type 1B, normal leaflet motion: leaflet perforation (A) mitral regurgitation and (B) aortic regurgitation.
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view however, the PISA in AR is perpendicular to 
the angle of insonation (and therefore unreliable), 
and in the apical window it is in the far field and 
is often too small to measure reliably. In addition, 
the pulse Doppler method used to calculate stroke 
volumes across the mitral valve and left ventric-
ular outflow tract (AR RVol=SVol LVOT–SVol MV) 
is subject to large interobserver variability.22 
Other methods such as pressure half time of the 
AR Doppler slope can be helpful to identify mild 
or severe disease but may be unreliable when 
there are changes in LV compliance or use of 
antihypertensive medication, and likewise, aortic 
diastolic flow reversal in the descending aorta 
may be useful but can also occur due to changes in 
aortic distensibility in the elderly.
There is increasing recognition of the limitations 
of echocardiography in quantifying regurgitation, 
particularly in differentiating moderate from severe 
regurgitation.23 CMR has the advantage of direct 
flow quantification using phase contrast velocity 
mapping. When used in the aortic root, this can 
quantify AR Rvol directly and can also be used 
to quantify MR indirectly, in conjunction with LV 
stroke volumes (MR RVol=LV stroke volume–
aortic forward flow). This has greater reproduc-
ibility than multiparametric echocardiography 
for RVol and grade24 and has good accuracy in in 
vitro models.25 Echo tends to overestimate severity 
compared with CMR, especially when MR varies 
throughout systole,26 and CMR is a better predictor 
of the future requirement for surgery, and ventric-
ular remodelling postsurgery in the limited number 
of studies to date.27 28 Cut- offs that predict adverse 
events or need for intervention are therefore lower 
for both MR28 and AR,29 and are not always the 
same as guidelines based on echo parameters (see 
table 3). CMR is not without problems, including 
background phase offset error, variation in volumes 
due to difference in selection of the basal slice 
and impact of irregular heart rhythms, and is not 
as widely available as echocardiography. CMR is 
most useful for sorting out difficult cases, such as 
Figure 3 Carpentier type 2: excessive leaflet motion with prolapse of leaflet tip behind annulus (A) mitral regurgitation and (B) aortic regurgitation.
Figure 4 Carpentier type 3A: restrictive leaflet motion—systole and diastole: rheumatic (A) mitral regurgitation and (B) aortic regurgitation.
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Table 3 Multiparametric assessment of regurgitation
Parameter Advantages Limitations Mild Severe
2D colour Doppler jet area
  
Easy screening for mild or 
severe




 ► Wall hugging.
 ► Eccentric.
Variable a/c to
 ► Machine settings.
 ► Haemodynamics.
Narrow origin, small Wide origin, large
MR >50% MR/LA area
AR>65% jet width/LVOT




Good for mild or severe
Independent of flow and 
pressure




Must be measured when US is 
perpendicular
<3 mm MR >7 mm
AR >6 mm




If absent, specific for mild
Multiple jets
 ► Overestimates if transient.
 ► Non- hemispheric.
Underestimates if
 ► Wall hugging.
 ► Eccentric.
If no flow convergence 
can be seen
>10 mm if Nyquist 30–40 cm/s





If PISA non- hemispheric








Dense triangular shape 




































Not useful if multiple valve 
disease
Primary MR RVol 
<30 mL
MR RF <30%
AR RVol <30 mL
AR RF <30%
Primary MR RVol >60 mL
MR RF >50%
Secondary MR RVol >30 mL






Not affected by irregular, 
eccentric, multiple or 
dynamic jets
Easy to measure
Accurate measures often require 
good correction of background 
flow offset error
Slight tendency for AR quantities 
to be underestimated
Not available in all hospitals






Holodiastolic descending aorta 
flow reversal
MR only         





Altered by LA/LV pressure 
gradient
A wave dominant
Specific for mild MR
E Vmax >1.5 m/s
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‘moderate–severe MR’, discrepancy between symp-
toms and regurgitation grade, exercise capacity and 
severity of regurgitation on echo, and where TTE 
images are suboptimal.
ASSESSING THE CONSEQUENCES OF 
REGURGITATION
Chronic AR is characterised by combined volume 
and pressure overload. The LV increases diastolic 
volume to accommodate AR, which results in 
increased diastolic wall stress. As the LV must eject 
a greater stroke volume over the same systolic 
ejection period, systolic pressure, afterload and 
systolic wall stress progressively increase. The 
combination of volume and pressure overload 
result in LV dilatation, eccentric LV hypertrophy, 
and increased interstitial fibrosis, which are 
progressive with increasing severity of AR and 
can lead ultimately to heart failure and death.30 In 
chronic MR, volume overload produces similar LV 
changes, with gradual transition from a compen-
sated phase, transitioning to LV impairment and 
ultimately decompensation.31 There is some CMR 
evidence that AR results in higher LV volumes for 
the same quantity of regurgitation, suggesting a 
differential LV response.32 Current guidelines 
emphasise the role of tracking LV chamber size 
and function, with cut- offs for intervention in 
asymptomatic patients based on linear dimensions 
and ejection fraction on TTE33 (tables 3). There 
are obvious limitations to using a single linear 
dimension as a trigger for intervention, not least 
that in primary MR, there is preferential remodel-
ling of the LV in the apex and mid cavity.34 Volu-
metric data have not however, been established in 
guidelines as a trigger, whether by contrast TTE, 
3D TTE or CMR, despite the greater reproduc-
ibility and accuracy in tracking change. Likewise, 
there are limitations to the use of ejection fraction 
in regurgitation, which measures chamber size 
rather than myocardial contractility and is altered 
by the RVol itself.
Multiple alternatives have been proposed 
for early detection of myocardial dysfunction, 
including fall in systolic and early myocardial 
relaxation velocities on tissue Doppler, reduction 
in strain, contractile reserve on stress echocardiog-
raphy, and fibrosis on CMR, none of which have 
been accepted into guidelines or been subjected to 
randomised trial end- point adjudication.35
Measuring left atrial volume, RV size and func-
tion, and maximal velocity of the regurgitant TR 
jet are all important parts of the imaging assess-
ment of the patient with MR that carry prognostic 
weight, and provide supportive evidence for a 
decision to intervene.16 It is important to recog-
nise the limitations in accuracy of the calculation 
of pulmonary artery systolic pressure by echocar-
diography however, and the need for confirma-
tion of the estimation of pulmonary pressure by 
invasive testing.36 CMR offers greater inter- study 
reproducibility for volume measures of LV, RV and 
LA chamber size and ejection fraction, compared 
even to 3D TTE with or without contrast but 
proof of an advantage in routine assessment of the 
asymptomatic patient with MR or AR is lacking.37
SUMMARY
Imaging assessment of the patient with MR or AR 
requires detailed assessment of the valve appa-
ratus, associated cardiac chambers, the aortic root 
(for AR) and flow quantification (for CMR) to 
identify the cause and mechanism of regurgitation, 
severity, and haemodynamic impact on ventric-
ular and atrial remodelling, as well as the effect on 
pulmonary pressure. Transthoracic echocardiog-
raphy remains the workhorse but requires careful 
integration of multiple parameters that vary in 
sensitivity and specificity, particularly when the 
Parameter Advantages Limitations Mild Severe




Useful in eccentric or 
multiple jets
Systolic blunting occurs if high 
LA or LV end- diastolic pressure
Other causes for high E Vmax
Systolic flow dominant Systolic flow reversal
AR only         




If present in abdominal 
aorta, specific for severe 
AR
Less reliable when aortic 
stiffness increased (age)
Depends on alignment of 
Doppler with jet direction
Variable according to location 
of sample
Brief flow reversal is 
normal
Holodiastolic, end- diastolic 
flow Vmax>20 cm/s




If long, specific for mild
Affected by any factor altering 
aortic- LV pressure gradient
Depends on alignment of 
Doppler with jet direction
>500 ms <200 ms
a/c, according to; AR, aortic regurgitation; CF, colour flow; CMR, cardiovascular magnetic resonance; EROA, effective regurgitant orifice; LA, left atrium; LV, left ventricle; 
LVOT, left ventricular outflow tract; MR, mitral regurgitation; MV, mitral valve; PISA, proximal isovelocity surface area; RF, regurgitant fraction; RVol, regurgitant volume; TOE, 
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aetiology is ischaemic, and the skill to use 3D 
regularly. Where data are conflicting, imaging is 
suboptimal or when intervention is under consid-
eration, either transoesophageal echocardiog-
raphy or CMR can be used, with 3D an integral 
component for complete TOE assessment.
Twitter Richard Paul Steeds @RichardSteeds
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